healthcare antitrust


Pfizer Completes $5.4 Billion Acquisition of Sickle Cell Disease Drug Innovator

Pfizer Inc. has acquired Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company whose leading product inhibits harmful medical conditions that lead to the relatively rare…

Courts Reject Two DOJ Merger Challenges as Another is On Trial

A brief setback for Biden’s war on anticompetitive deals? The number of mergers globally in 2021, according to PwC, was the biggest on record with…

FTC Sues to Block Illumina/Grail Deal

The Federal Trade Commission has filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail —…

Hospital Merger Activity and Challenges: Two Conclude, One Merger Abandoned

Deal activity in the trillion-dollar U.S. patient-care industry has been hardy, despite projections that the pandemic might have slowed things down. That means the federal…